CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test
The CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test is an advanced diagnostic tool that plays a vital role in identifying genetic mutations linked to primary ciliary dyskinesia (PCD). PCD is a genetic disorder that affects the cilia, the small hair-like structures that play a crucial role in clearing mucus and pathogens from the respiratory tract. This test utilizes Next-Generation Sequencing (NGS) technology, providing a comprehensive analysis of the CFAP298 gene to detect potential mutations.
What the Test Measures/Detects
This genetic test specifically measures variations in the CFAP298 gene, which are implicated in the development of primary ciliary dyskinesia. By examining the genetic code, the test can identify mutations that may lead to abnormal ciliary function, resulting in respiratory issues and other related health problems.
Who Should Consider This Test?
This test is recommended for individuals who exhibit symptoms such as:
- Chronic respiratory infections
- Frequent ear infections
- Persistent sinusitis
- Infertility issues in men
- Congenital heart defects
Additionally, those with a family history of primary ciliary dyskinesia or related conditions should consider this test for better insight into their genetic predisposition.
Benefits of Taking the Test
- Early identification of genetic mutations associated with PCD.
- Informed decision-making regarding treatment and management of symptoms.
- Ability to undergo genetic counseling for family planning.
- Understanding of potential health risks and proactive health management.
Understanding Your Results
Once the test is completed, results will be interpreted by a qualified genetic counselor or physician. They will provide guidance on what the results mean for your health, potential risks, and the next steps. It is essential to have a thorough understanding of your genetic profile to make informed health decisions.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
How to Book the Test
Don’t wait to take control of your health! To book the CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test, call or WhatsApp us at +2348077798758. Our team is ready to assist you with any questions and guide you through the booking process.
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood or extracted DNA, or even one drop of blood on an FTA card. Prior to the test, a clinical history of the patient is essential, along with a genetic counseling session to draw a pedigree chart of family members affected by PCD.
Take the first step towards understanding your genetic health with the CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test.
